Tuesday, July 14, 2026
6:00 – 6:30 p.m. ET | Registration & dinner
6:30 – 8:00 p.m. ET | CME presentation & dessert
Renaissance Atlanta Midtown Hotel
866 W. Peachtree Street NW
Atlanta, GA 30308
Meeting room: Centennial Ballroom
PROGRAM FEATURES
- 1.5 CME & CNE Credit
- Interactive case-based discussion
- Real patient cases from the Day in the Life docuseries
- Whiteboard animations
- A variety of point-of-care tools & resources
- Patient advocacy resource station
FACULTY
 |
Stephanie L. Gold, MD Assistant Professor of Medicine Icahn School of Medicine at Mount Sinai Gastroenterologist Mount Sinai Hospital New York, New York |
 |
Elizabeth A. Spencer, MD, MS Associate Professor of Pediatric Gastroenterology Associate Program Director, Pediatric Research Residency Director, Pediatric IBD Translational Research Program Co-Director, IBD-Dermatology Multidisciplinary Clinic Co-Director, IBD Prevention Clinic Icahn School of Medicine New York, New York |
PROGRAM OVERVIEW
This gastroenterology-focused CME summit uses interactive, case-based discussions to examine the shared inflammatory messengers that link obesity with inflammatory bowel disease (IBD) and contribute to both intestinal and systemic pathology. Faculty will guide participants in applying current obesity treatment guideline recommendations and supporting evidence to real-world IBD scenarios involving patients with excess body weight. Through collaborative problem solving and multidisciplinary dialogue, attendees will explore practical strategies to build and sustain coordinated care teams that optimize outcomes for patients navigating both IBD and obesity.
TARGET AUDIENCE
This educational activity is intended to educate rheumatologists, gastroenterologists, dermatologists, and related advanced practice providers in the care of patients with obesity and IMIDs.
LEARNING OBJECTIVES
Upon the completion of this program, attendees should be able to:
- Describe the immune messengers common to both obesity and IMIDs and their resultant corresponding pathologies
- Incorporate obesity treatment guideline recommendations and their supporting data into the management of patients with both IMIDs and excess body weight
- Develop and maintain a collaborative multidisciplinary team to optimize care for the patient with IMIDs and obesity
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this live activity for a maximum of 1.5 ANCC contact hours.
ACCME INNOVATION PARTNER – US Learners Only
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to participating at [email protected]
